These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 18087285)

  • 1. Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma.
    Yoshikawa D; Ojima H; Iwasaki M; Hiraoka N; Kosuge T; Kasai S; Hirohashi S; Shibata T
    Br J Cancer; 2008 Jan; 98(2):418-25. PubMed ID: 18087285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX4 is associated with poor prognosis in cholangiocarcinoma.
    Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S
    Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of EGFR family gene aberrations in cholangiocarcinoma.
    Yang X; Wang W; Wang C; Wang L; Yang M; Qi M; Su H; Sun X; Liu Z; Zhang J; Qin X; Han B
    Oncol Rep; 2014 Aug; 32(2):700-8. PubMed ID: 24927194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
    World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma.
    Miyamoto M; Ojima H; Iwasaki M; Shimizu H; Kokubu A; Hiraoka N; Kosuge T; Yoshikawa D; Kono T; Furukawa H; Shibata T
    Br J Cancer; 2011 Jun; 105(1):131-8. PubMed ID: 21673683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma.
    Aishima S; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Mod Pathol; 2008 Mar; 21(3):256-64. PubMed ID: 18192971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of long non‑coding RNA CCAT2 indicates a poor prognosis and promotes proliferation and metastasis in intrahepatic cholangiocarcinoma.
    Bai JG; Tang RF; Shang JF; Qi S; Yu GD; Sun C
    Mol Med Rep; 2018 Apr; 17(4):5328-5335. PubMed ID: 29393466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.
    Park BK; Paik YH; Park JY; Park KH; Bang S; Park SW; Chung JB; Park YN; Song SY
    Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinase-7 is an unfavorable prognostic factor in intrahepatic cholangiocarcinoma.
    Hirashita T; Iwashita Y; Ohta M; Komori Y; Eguchi H; Yada K; Kitano S
    J Gastrointest Surg; 2012 Apr; 16(4):842-8. PubMed ID: 22246855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of cystathionine beta-synthase and chemokine ligand 21 is closely associated with poor prognosis in extrahepatic cholangiocarcinoma.
    Wang L; Yang Z; Wu Z; He J; Xu S; Li D; Zou Q; Yuan Y
    Medicine (Baltimore); 2020 Sep; 99(38):e22255. PubMed ID: 32957374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.
    Guo S; Liu HD; Liu YF; Liu L; Sun Q; Cui XJ
    Tumour Biol; 2015 Jan; 36(1):353-64. PubMed ID: 25262276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Homer1 as a potential prognostic marker for intrahepatic cholangiocarcinoma.
    Wu SY; Yu MX; Li XG; Xu SF; Shen J; Sun Z; Zhou X; Chen XZ; Tu JC
    Asian Pac J Cancer Prev; 2014; 15(7):3299-304. PubMed ID: 24815486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression levels and significance of nuclear factor-κB and epidermal growth factor receptor in hepatolithiasis associated with intrahepatic cholangiocarcinoma.
    Zhou Q; Gong Y; Huang F; Lin Q; Zeng B; Li Z; Chen R
    Dig Surg; 2013; 30(4-6):309-16. PubMed ID: 24008372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.
    Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J
    Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis.
    Huang Q; Liu L; Liu CH; You H; Shao F; Xie F; Lin XS; Hu SY; Zhang CH
    Asian Pac J Cancer Prev; 2013; 14(2):829-34. PubMed ID: 23621247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma.
    Yang SZ; Wang AQ; Du J; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
    World J Gastroenterol; 2016 Jul; 22(25):5814-21. PubMed ID: 27433094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression.
    Fava G; Demorrow S; Gaudio E; Franchitto A; Onori P; Carpino G; Glaser S; Francis H; Coufal M; Marucci L; Alvaro D; Marzioni M; Horst T; Mancinelli R; Benedetti A; Alpini G
    Liver Int; 2009 Aug; 29(7):1031-42. PubMed ID: 19291182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.
    Andersen JB; Spee B; Blechacz BR; Avital I; Komuta M; Barbour A; Conner EA; Gillen MC; Roskams T; Roberts LR; Factor VM; Thorgeirsson SS
    Gastroenterology; 2012 Apr; 142(4):1021-1031.e15. PubMed ID: 22178589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.